Evidence map›Paper›PMID 36986610›Full record

ReviewPharmaceutics2023

Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection.

Shoaib Shoaib, Mohammad Azam Ansari, Adel Al Fatease, Awaji Y Safhi, Umme Hani, Roshan Jahan, Mohammad N Alomary, Mohd Nazam Ansari, Nabeel Ahmed, Shadma Wahab and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Effects ofJournal of Taibah University Medical Sciences · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Plants (Basel, Switzerland) · 2026
    Review
  10. Review
  11. Article
  12. Unveiling the multifaceted potential ofJournal of pharmaceutical analysis · 2026
    Review
  13. Article
  14. Review
  15. Anti-Inflammatory and Antioxidant Properties ofInternational journal of molecular sciences · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Therapeutic Potential ofJournal of inflammation research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Shoaib ShoaibDepartment of Biochemistry, Faculty of Medicine, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India.
Mohammad Azam AnsariDepartment of Epidemic Disease Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.ORCID 0000-0002-6122-5479
Adel Al FateaseDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0002-4608-5949
Awaji Y SafhiDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0000-0002-2184-4339
Umme HaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0003-4643-0922
Roshan JahanDepartment of Botany, Faculty of Lifesciences, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India.
Mohammad N AlomaryAdvanced Diagnostic and Therapeutic Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.ORCID 0000-0001-7909-4377
Mohd Nazam AnsariDepartment of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharaj 11942, Saudi Arabia.ORCID 0000-0001-8580-3002
Nabeel AhmedDepartment of Life Sciences, Shiv Nadar University, Greater Noida 201314, Uttar Pradesh, India.
Shadma WahabDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0001-9941-2918
Wasim AhmadDepartment of Pharmacy, Mohammed Al-Mana College for Medical Sciences, Dammam 34222, Saudi Arabia.ORCID 0000-0003-2639-9200
Nabiha YusufDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-5730-0037
Najmul IslamDepartment of Biochemistry, Faculty of Medicine, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India.
Aligarh Muslim University · INKing Khalid University · SAPrince Sattam Bin Abdulaziz University · SAJazan University · SAKing Abdulaziz City for Science and Technology · SAShiv Nadar University · INUniversity of Alabama at Birmingham · US

Funding

King Khalid University RGP, 1/270/43
6 · The paper itself

Abstract

Neurodegenerative disorders encompass a wide range of pathological conditions caused by progressive damage to the neuronal cells and nervous-system connections, which primarily target neuronal dysfunction and result in problems with mobility, cognition, coordination, sensation, and strength. Molecular insights have revealed that stress-related biochemical alterations such as abnormal protein aggregation, extensive generation of reactive oxygen and nitrogen species, mitochondrial dysfunction, and neuroinflammation may lead to damage to neuronal cells. Currently, no neurodegenerative disease is curable, and the available standard therapies can only provide symptomatic treatment and delay the progression of the disease. Interestingly, plant-derived bioactive compounds have drawn considerable attention due to their well-established medicinal properties, including anti-apoptotic, antioxidant, anti-inflammatory, anticancer, and antimicrobial properties, as well as neuroprotective, hepatoprotective, cardioprotective, and other health benefits. Plant-derived bioactive compounds have received far more attention in recent decades than synthetic bioactive compounds in the treatment of many diseases, including neurodegeneration. By selecting suitable plant-derived bioactive compounds and/or plant formulations, we can fine tune the standard therapies because the therapeutic efficacy of the drugs is greatly enhanced by combinations. A plethora of in vitro and in vivo studies have demonstrated plant-derived bioactive compounds' immense potential, as proven by their capacity to influence the expression and activity of numerous proteins implicated in oxidative stress, neuroinflammation, apoptosis, and aggregation. Thus, this review mostly focuses on the antioxidant, anti-inflammatory, anti-aggregation, anti-cholinesterase, and anti-apoptotic properties of several plant formulations and plant-derived bioactive compounds and their molecular mechanisms against neurodegenerative disorders.

Indexed as

amyloid βantioxidantcholinesterasedementianeurodegenerative disordersneuroinflammationphytocompoundsplant formulations

Identifiers

PMID36986610
PMCPMC10057544
OpenAlexW4321787376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.